Cliff Asness’s Perspective Therapeutics CATX Stock Holding History

Cliff Asness’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$95.5K	Buy	27,998 +1,282	+5%	+$4.84K	﹤0.01%	3859
2026 Q1	$111K	Buy	+26,716	New	+$113K	﹤0.01%	3673
2015 Q4	–	Sell	-7,216	Closed	-$101K	–	2244
2015 Q3	$101K	Sell	7,216 -10,027	-58%	-$145K	﹤0.01%	2128
2015 Q2	$255K	Sell	17,243 -1,227	-7%	-$19.9K	﹤0.01%	2037
2015 Q1	$290K	Sell	18,470 -770	-4%	-$11.4K	﹤0.01%	1888
2014 Q4	$281K	Buy	19,240 +4,830	+34%	+$76.5K	﹤0.01%	2230
2014 Q3	$244K	Buy	14,410 +4,850	+51%	+$120K	﹤0.01%	2261
2014 Q2	$298K	Buy	+9,560	New	+$240K	﹤0.01%	2217

Other funds holding CATX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

SSC

Spruce Street Capital New York $510M AUM

Cliff Asness's CATX Position: Q2 2026 in Review

Cliff Asness increased its Perspective Therapeutics (CATX) stake by 4.8% in Q2 2026, buying an estimated $4.84K and bringing the position to 27,998 shares worth $95.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3859.

Cliff Asness first reported a position in CATX in Q2 2014 and has held it in 8 quarters since. The position peaked at $298K in Q2 2014. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

Cliff Asness held 27,998 shares of Perspective Therapeutics worth $95.5K as of Q2 2026.
Cliff Asness bought 1,282 Perspective Therapeutics shares in Q2 2026, an estimated $4.84K.
Perspective Therapeutics made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3859 holding.
Cliff Asness first reported a position in Perspective Therapeutics in Q2 2014 and has held it in 8 quarters since.
Cliff Asness's Perspective Therapeutics position peaked at $298K in Q2 2014.
131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.